•
Mar 31, 2021

Voyager Therapeutics Q1 2021 Earnings Report

Total Revenue
$6.5M
Previous year: $18.1M
-64.0%
EPS
-$0.58
Previous year: -$0.66
-12.1%
Gross Profit
-$15.8M
Cash and Equivalents
$118M
Free Cash Flow
-$21.7M
Total Assets
$238M

Voyager Therapeutics

Voyager Therapeutics